Table 2 Distribution of medications in women and men.
From: Platelet-neutrophil conjugate formation is increased in diabetic women with cardiovascular disease
Medication (%) | NDW-CVD (n = 23) | NDW+CVD (n = 25) | DW-CVD (n = 20) | DW+CVD (n = 24) | NDM+CVD (n = 8) | DM+CVD (n = 18) |
|---|---|---|---|---|---|---|
Beta Blockersψ | 0% | 48% | 10% | 46% | 50% | 53% |
Diureticsψ | 4% | 20% | 10% | 63% | 50% | 71% |
Nitratesψ | 4% | 16% | 0% | 21% | 0% | 53% |
ACE Inhibitorsψ | 4% | 20% | 65% | 38% | 63% | 41% |
Positive Intropes | 0% | 8% | 5% | 21% | 0% | 12% |
Ca2+ Channel Blockersψ | 0% | 16% | 10% | 29% | 38% | 29% |
Aspirinψ | 21% | 56% | 25% | 79% | 63% | 59% |
Anti-coagulants | 0% | 12% | 10% | 4% | 25% | 0% |
Antioxidantsψ | 50% | 28% | 10% | 13% | 0% | 0% |
Hypoglycemic Agentsψ | 0% | 0% | 65% | 21% | 0% | 29% |
Statins | 12% | 29% | 25% | 34% | 75% | 38% |
HRT | 50% | 64% | 55% | 42% | N/A | N/A |